Viper ULTRA Thrombolysis Catheter

Viper ULTRA Thrombolysis Catheter

An ultra infusion catheter specialized for direct thrombolytic delivery, featuring multi-hole design to uniformly distribute drugs across large clot segments.

정보

그리고 Viper® Ultrasonic Pharmacomechanical Thrombolysis System 는 최소 침습적 device designed to dissolve thrombi by combining targeted ultrasonic waves with controlled tPA infusion. By thinning fibrin 그리고 increasing clot porosity, the system enables deeper drug penetration into the thrombus, thereby enhancing the efficacy of pharmacological therapy. This approach helps mitigate potential bleeding complications 그리고 preserves vessel integrity, offering a more refined, patient-centric strategy for acute thrombosis management.

Ultrasonic Wave Delivery
  • Controlled Ultrasound: Low-power ultrasonic energy focuses on fibrin disruption, loosening the structural integrity of the clot.
  • Enhanced Porosity: Breaking fibrin strands encourages tPA to penetrate deeper, ensuring thorough thrombus dissolution.
  • tPA Administration: A site-specific delivery of tissue plasminogen activator (tPA) directly into the clot.
  • Synergistic Effect: Ultrasonic micro-cavitation augments the fibrinolytic effect, requiring lower drug doses and potentially reducing hemorrhagic complications.
  • Minimal Vessel Trauma: Ultrasonic waves are calibrated to avoid damaging valves, vessel walls, or critical structures within the venous or pulmonary vasculature.
  • Reduced Bleeding Risk: Lower overall drug usage and localized infusion can curtail systemic side effects.
  • Controlled Ultrasound: Low-power ultrasonic energy focuses on fibrin disruption, loosening the structural integrity of the clot.
  • Enhanced Porosity: Breaking fibrin strands encourages tPA to penetrate deeper, ensuring thorough thrombus dissolution.
  • tPA Administration: A site-specific delivery of tissue plasminogen activator (tPA) directly into the clot.
  • Synergistic Effect: Ultrasonic micro-cavitation augments the fibrinolytic effect, requiring lower drug doses and potentially reducing hemorrhagic complications.
  • Minimal Vessel Trauma: Ultrasonic waves are calibrated to avoid damaging valves, vessel walls, or critical structures within the venous or pulmonary vasculature.
  • Reduced Bleeding Risk: Lower overall drug usage and localized infusion can curtail systemic side effects.

제품 사양

사양 세부 정보 / 값
제품 이름 Viper ULTRA Thrombolysis Catheter
사용 목적 Catheter-directed infusion of thrombolytics in acute or subacute thrombus (peripheral, venous, or arterial)
카테터 디자인 Multi-hole distal segment for uniform drug dispersion, possible radiopaque marker at tip
재료 Pebax/Polyamide shaft, potentially braided or reinforced
외경(F) ~4–6F (depending on infusion lumen capacity)
작업 길이 ~80–150 cm (varies by product code)
Infusion Ports Distributed side ports over a defined segment for consistent thrombolytic delivery
가이드 와이어 호환성 Typically 0.014” or 0.018”
무균 멸균, 일회용
유통 기한 ~2–3 years if stored at 15–25 °C in sealed packaging
임상 적응증 Thrombolytic infusion for DVT, peripheral arterial occlusions, possibly for intra-graft thrombosis
금기 사항 Highly calcified lesions, severe vessel tortuosity preventing safe passage, known device material allergies

주문 및 사이즈 매트릭스

외경(F) 작업 길이(cm) Infusion Segment (cm) 제품 코드 참고
4F 80 10 VPR-4F-80-10 Smaller OD for distal or small vessel usage
4F 120 15 VPR-4F-120-15 Longer shaft, moderate infusion segment
5F 80 10 VPR-5F-80-10 Slightly larger OD for heavier clot load
5F 120 20 VPR-5F-120-20 Extended length with longer infusion zone
6F 100 15 VPR-6F-100-15 Common size for multi-level peripheral lesions
6F 150 30 VPR-6F-150-30 Max length, extensive infusion segment

연관 상품